Forteo and Cogentin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Forteo (teriparatide recombinant human) and Cogentin (benztropine mesylate). Common drug interactions include speech disorder among females and cardio-respiratory arrest among males.

The phase IV clinical study analyzes what interactions people have when they take Forteo and Cogentin. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Forteo?

Forteo has active ingredients of teriparatide recombinant human. It is often used in osteoporosis. eHealthMe is studying from 127,076 Forteo users. Check the latest studies of Forteo.

What is Cogentin?

Cogentin has active ingredients of benztropine mesylate. It is often used in tardive dyskinesia. eHealthMe is studying from 7,692 Cogentin users. Check the latest studies of Cogentin.



On Aug, 11, 2026

15 people who take Forteo and Cogentin together, and have interactions are studied.

Forteo and Cogentin drug interactions.

What are the common drug interactions of Forteo and Cogentin, by gender? *:

female:

  1. Speech disorder
  2. Tooth injury
  3. Upper limb fracture
  4. Tooth fracture
  5. Overdose
  6. Bone pain
  7. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  8. General physical health deterioration (weak health status)
  9. Hypocalcaemia (levels of calcium in blood serum are abnormally low)
  10. Myalgia (muscle pain)

male:

  1. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  2. Acute myocardial infarction (acute heart attack)
  3. Loss of consciousness
  4. Unresponsive to stimuli

What are the common drug interactions of Forteo and Cogentin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  2. General physical health deterioration (weak health status)
  3. Hypocalcaemia (levels of calcium in blood serum are abnormally low)
  4. Overdose
  5. Electrolyte imbalance
  6. Muscle spasms (muscle contraction)
  7. Pathological fracture (broken bone caused by disease)
  8. Vein disorder
  9. Acute myocardial infarction (acute heart attack)
  10. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)

50-59:

  1. Tooth injury
  2. Upper limb fracture
  3. Dizziness
  4. Tooth fracture
  5. Bone pain
  6. Myalgia (muscle pain)
  7. Weight increased
  8. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  9. Fall
  10. Injection site haematoma (localized swelling filled with blood at injection site)

60+:

  1. Activities of daily living impaired
  2. Anxiety
  3. Culture urine positive
  4. Deformity (disfigurement)
  5. Dental caries
  6. Dizziness
  7. Duodenal ulcer
  8. Dyskinesia (abnormality or impairment of voluntary movement)
  9. Enterococcus test positive
  10. Epstein-barr virus infection

What are the existing conditions these people have? *

  1. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 4 people, 26.67%
  2. Hypoparathyroidism (inadequate secretion of parathyroid hormone resulting in abnormally low levels of calcium in the blood): 1 person, 6.67%
  3. Hypocalcaemia (levels of calcium in blood serum are abnormally low): 1 person, 6.67%
  4. Gastrointestinal Disorder (functional problems of gastrointestinal tract): 1 person, 6.67%
  5. Abdominal Pain: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Forteo and Cogentin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Forteo and Cogentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Forteo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cogentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Forteo and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cogentin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on teriparatide recombinant human and benztropine mesylate (the active ingredients of Forteo and Cogentin, respectively), and Forteo and Cogentin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: